O6-methylguanine-DNA methyltransferase (MGMT) is a strong prognostic biomarker in patients with glioblastoma.[9] In mammals, the MGMT protein and the Mismatch Repair system play crucial roles in maintaining the stability of DNA. The gene discussed is MGMT; the disease is glioblastoma.